303 related articles for article (PubMed ID: 11513731)
1. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells.
Mercier N; Moldes M; El Hadri K; Fève B
Biochem J; 2001 Sep; 358(Pt 2):335-42. PubMed ID: 11513731
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage. differentiation-dependent expression, regulation, and identification as semicarbazide-sensitive amine oxidase.
Moldes M; Fève B; Pairault J
J Biol Chem; 1999 Apr; 274(14):9515-23. PubMed ID: 10092636
[TBL] [Abstract][Full Text] [Related]
3. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.
Bour S; Daviaud D; Gres S; Lefort C; Prévot D; Zorzano A; Wabitsch M; Saulnier-Blache JS; Valet P; Carpéné C
Biochimie; 2007 Aug; 89(8):916-25. PubMed ID: 17400359
[TBL] [Abstract][Full Text] [Related]
4. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-alpha in adipocytes: functional consequences on glucose transport.
Mercier N; Moldes M; El Hadri K; Fève B
J Pharmacol Exp Ther; 2003 Mar; 304(3):1197-208. PubMed ID: 12604697
[TBL] [Abstract][Full Text] [Related]
5. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C
J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044
[TBL] [Abstract][Full Text] [Related]
6. Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells.
Fontana E; Boucher J; Marti L; Lizcano JM; Testar X; Zorzano A; Carpéné C
Biochem J; 2001 Jun; 356(Pt 3):769-77. PubMed ID: 11389684
[TBL] [Abstract][Full Text] [Related]
7. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes.
Carpéné C; Daviaud D; Boucher J; Bour S; Visentin V; Grès S; Duffaut C; Fontana E; Testar X; Saulnier-Blache JS; Valet P
Metabolism; 2006 Oct; 55(10):1397-405. PubMed ID: 16979412
[TBL] [Abstract][Full Text] [Related]
9. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells.
Enrique-Tarancón G; Marti L; Morin N; Lizcano JM; Unzeta M; Sevilla L; Camps M; Palacín M; Testar X; Carpéné C; Zorzano A
J Biol Chem; 1998 Apr; 273(14):8025-32. PubMed ID: 9525902
[TBL] [Abstract][Full Text] [Related]
10. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
11. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
[TBL] [Abstract][Full Text] [Related]
12. Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter.
Grès S; Bour S; Valet P; Carpéné C
J Physiol Biochem; 2012 Dec; 68(4):651-62. PubMed ID: 22547093
[TBL] [Abstract][Full Text] [Related]
13. Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism.
Iglesias-Osma MC; Bour S; Garcia-Barrado MJ; Visentin V; Pastor MF; Testar X; Marti L; Enrique-Tarancon G; Valet P; Moratinos J; Carpéné C
Pharmacol Res; 2005 Dec; 52(6):475-84. PubMed ID: 16135411
[TBL] [Abstract][Full Text] [Related]
14. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
15. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
Enrique-Tarancón G; Castan I; Morin N; Marti L; Abella A; Camps M; Casamitjana R; Palacín M; Testar X; Degerman E; Carpéné C; Zorzano A
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of methylamine by semicarbazide-sensitive amine oxidase in white and brown adipose tissue of the rat.
Conforti L; Raimondi L; Lyles GA
Biochem Pharmacol; 1993 Aug; 46(4):603-7. PubMed ID: 8363633
[TBL] [Abstract][Full Text] [Related]
17. Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake.
El Hadri K; Moldes M; Mercier N; Andreani M; Pairault J; Feve B
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):89-94. PubMed ID: 11788466
[TBL] [Abstract][Full Text] [Related]
18. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
19. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
Yu PH; Wang M; Fan H; Deng Y; Gubisne-Haberle D
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E634-41. PubMed ID: 14656718
[TBL] [Abstract][Full Text] [Related]
20. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
Abella A; García-Vicente S; Viguerie N; Ros-Baró A; Camps M; Palacín M; Zorzano A; Marti L
Diabetologia; 2004 Mar; 47(3):429-438. PubMed ID: 14968297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
